Fexofenadine Counteracts Osimertinib Resistance in Non-Small Cell Lung Cancer by Targeting c-Met
In a groundbreaking advancement in cancer therapeutics, researchers have unveiled a novel approach to combat resistance to osimertinib, a frontline treatment for advanced non-small cell...
















